Inhaler devices for chronic obstructive pulmonary disease: insights from patients and healthcare practitioners.
about
Patients' perspectives and preferences in the choice of inhalers: the case for Respimat(®) or HandiHaler(®)A real-world evaluation of indacaterol and other bronchodilators in COPD: the INFLOW study.Tiotropium Respimat(®) vs. HandiHaler(®): real-life usage and TIOSPIR trial generalizability.Assessment of satisfaction with different dry powder inhalation devices in Greek patients with COPD and asthma: the ANASA study.The efficacy and safety of combined tiotropium and olodaterol via the Respimat(®) inhaler in patients with COPD: results from the Japanese sub-population of the Tonado(®) studiesOptimising Inhaled Pharmacotherapy for Elderly Patients with Chronic Obstructive Pulmonary Disease: The Importance of Delivery Devices.Perception of symptoms and quality of life - comparison of patients' and physicians' views in the COPD MIRROR study.Inhalation device options for the management of chronic obstructive pulmonary disease.Requirements, Strengths and Weaknesses of Inhaler Devices for COPD Patients from the Expert Prescribers' Point of View: Results of the EPOCA Delphi Consensus.Maintenance inhaler preference, attribute importance, and satisfaction in prescribing physicians and patients with asthma, COPD, or asthma-COPD overlap syndrome consulting for routine care.Practical considerations when prescribing a long-acting muscarinic antagonist for patients with COPD.Factors associated with appropriate inhaler use in patients with COPD - lessons from the REAL survey.Optimal Bronchodilation for COPD Patients: Are All Long-Acting β₂-Agonist/Long-Acting Muscarinic Antagonists the Same?
P2860
Q26738366-17B2A10E-9E25-489B-AD4B-2C2E5AE8C6C9Q35816973-63048F8E-FF9F-4AD0-948D-EB81EF8F1303Q36802125-41021BA7-838C-4512-8448-B365328B4AEBQ37167808-77FC3481-2907-4B3F-9F0D-EFCDFD581323Q37229624-BB9E5675-1E6D-4912-B43A-BF084B1B2100Q38842452-A541A1B5-7681-4E83-A1D5-73E6A98BC401Q41199541-46E6AF10-34F6-4866-8396-277F66FDDF49Q47279539-AEB06FF0-DC49-47A1-A238-882C648DAFEAQ47690910-9FF95391-EA9A-4A88-98D8-CA6011A2A55AQ54958121-0352DF6E-E18A-4FC5-B75A-3FB638606729Q55120067-54AF2AEB-8223-4781-B654-91687F6FFD04Q55283080-A97E044A-15BF-4367-8A09-E7943A94FB31Q55432750-078E3F01-684D-4EE9-8BCE-7C7844FD4B31
P2860
Inhaler devices for chronic obstructive pulmonary disease: insights from patients and healthcare practitioners.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Inhaler devices for chronic ob ...... and healthcare practitioners.
@ast
Inhaler devices for chronic ob ...... and healthcare practitioners.
@en
type
label
Inhaler devices for chronic ob ...... and healthcare practitioners.
@ast
Inhaler devices for chronic ob ...... and healthcare practitioners.
@en
prefLabel
Inhaler devices for chronic ob ...... and healthcare practitioners.
@ast
Inhaler devices for chronic ob ...... and healthcare practitioners.
@en
P2860
P356
P1476
Inhaler devices for chronic ob ...... and healthcare practitioners.
@en
P2093
Paul Colthorpe
P2860
P304
P356
10.1089/JAMP.2014.1142
P577
2014-09-29T00:00:00Z